KATHLEEN MILLER: Open Payments
NPI 1487022372 · JEFFERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 30 payments from 9 companies in 2025. Trend: 2023 $1,274 · 2024 $416 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $193 |
| ABBVIE INC. | 13 | $166 |
| Novo Nordisk Inc | 3 | $43 |
| Lilly USA, LLC | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Symbravo, VRAYLAR, QULIPTA, Auvelity, VOQUEZNA, KISUNLA, REXULTI, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
